94 / 140
216
16. Tam PE. Coxsackievirus myocarditis: interplay between virus and host
in the pathogenesis of heart disease. Viral Im- munol 2006;19:133-
146.
17. Leslie T. Cooper, Jr.Myocarditis. N Engl J Med 2009; 360:1526-1538
18. Fairweather D, Frisancho-Kiss S, Rose NR. Viruses as adjuvants for
autoimmuni- ty: evidence from Coxsackievirus-induced myocarditis.
Rev Med Virol 2005;15:17-27.
19. Sakaguchi S. Regulatory T cells: key controllers of immunologic
self-tolerance. Cell 2000;101:455-458.
20. Ono M, Shimizu J, Miyachi Y, Sakagu- chi S. Control of autoimmune
myocarditis and multiorgan inflammation by gluco- corticoid-
induced TNF receptor family- related protein(high), Foxp3-expressing
CD25+ and CD25- regulatory T cells. J Im- munol 2006;176:4748-
4756.
21. Huber SA, Budd RC, Rossner K, Newell MK. Apoptosis in coxsaquievirus
B3 induced myocarditis and dilated cardiomy- opathy. Ann N Y Acad
Sci 1999;887:181-190
22. Frustaci A, Russo MA, Chimenti C. Randomized study on the efficacy
of immunosuppressive therapy in patients with virus-negative
inflammatory cardiomyopathy: the TIMIC study. Eur Heart J.
2009;30:1995-2002.
23. Rapezzi C, Arbustini E, Caforio APL, et al. Diagnostic work-up in
cardiomyopathies: bridging the gap between clinical phenotypes and
final diagnosis. A position statement from the ESC Working Group on
Myocardial and Pericardial Diseases. Eur Heart J 2013;34: 1448–
1458.
[REV. MED. CLIN. CONDES - 2015; 26(2) 210-216]